Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1990 5
1991 8
1992 19
1993 24
1994 35
1995 45
1996 41
1997 39
1998 52
1999 44
2000 57
2001 44
2002 47
2003 46
2004 34
2005 55
2006 52
2007 62
2008 61
2009 50
2010 64
2011 56
2012 81
2013 77
2014 90
2015 93
2016 87
2017 101
2018 107
2019 83
2020 83
2021 84
2022 92
2023 83
2024 59

Text availability

Article attribute

Article type

Publication date

Search Results

1,845 results

Results by year

Filters applied: . Clear all
Page 1
Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
Tamura R. Tamura R. Int J Mol Sci. 2021 May 29;22(11):5850. doi: 10.3390/ijms22115850. Int J Mol Sci. 2021. PMID: 34072574 Free PMC article. Review.
The NF2 gene is identified on chromosome 22q12, which encodes for merlin, a tumor suppressor protein related to ezrin-radixin-moesin that modulates the activity of PI3K/AKT, Raf/MEK/ERK, and mTOR signaling pathways. ...This study discusses molecular pathways and related ta …
The NF2 gene is identified on chromosome 22q12, which encodes for merlin, a tumor suppressor protein related to ezrin-radixin-moesin …
Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
Bachir S, Shah S, Shapiro S, Koehler A, Mahammedi A, Samy RN, Zuccarello M, Schorry E, Sengupta S. Bachir S, et al. Int J Mol Sci. 2021 Jan 12;22(2):690. doi: 10.3390/ijms22020690. Int J Mol Sci. 2021. PMID: 33445724 Free PMC article. Review.
Patients diagnosed with neurofibromatosis type 2 (NF2) are extremely likely to develop meningiomas, in addition to vestibular schwannomas. Meningiomas are a common primary brain tumor; many NF2 patients suffer from multiple meningiomas. In NF
Patients diagnosed with neurofibromatosis type 2 (NF2) are extremely likely to develop meningiomas, in addition …
Neurofibromatosis type 2.
Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR. Asthagiri AR, et al. Lancet. 2009 Jun 6;373(9679):1974-86. doi: 10.1016/S0140-6736(09)60259-2. Epub 2009 May 22. Lancet. 2009. PMID: 19476995 Free PMC article. Review.
Neurofibromatosis type 2 is an autosomal-dominant multiple neoplasia syndrome that results from mutations in the NF2 tumour suppressor gene located on chromosome 22q. ...We review the molecular pathogenesis, genetics, clinical findings, and management
Neurofibromatosis type 2 is an autosomal-dominant multiple neoplasia syndrome that results from mutations in the NF2
An update on the CNS manifestations of neurofibromatosis type 2.
Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S. Coy S, et al. Acta Neuropathol. 2020 Apr;139(4):643-665. doi: 10.1007/s00401-019-02029-5. Epub 2019 Jun 4. Acta Neuropathol. 2020. PMID: 31161239 Free PMC article. Review.
NF2 results from loss-of-function alterations in the NF2 gene on chromosome 22, with resultant dysfunction of its protein product merlin. ...Here, we review the clinicopathologic features of NF2, current understanding of the molecular biology of NF2, p
NF2 results from loss-of-function alterations in the NF2 gene on chromosome 22, with resultant dysfunction of its protein prod
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas.
Cumpston EC, Rhodes SD, Yates CW. Cumpston EC, et al. Curr Oncol Rep. 2023 May;25(5):531-537. doi: 10.1007/s11912-023-01388-3. Epub 2023 Mar 18. Curr Oncol Rep. 2023. PMID: 36933171 Review.
PURPOSE OF REVIEW: Neurofibromatosis 2 (NF2) is an autosomal-dominant genetic disorder characterized by bilateral vestibular schwannomas (VS), meningiomas, ependymomas, spinal and peripheral schwannomas, optic gliomas, and juvenile cataracts. ...NF2-as …
PURPOSE OF REVIEW: Neurofibromatosis 2 (NF2) is an autosomal-dominant genetic disorder characterized by bilateral vesti …
Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator.
Beltrami S, Kim R, Gordon J. Beltrami S, et al. Anticancer Res. 2013 Jan;33(1):1-11. Anticancer Res. 2013. PMID: 23267122 Free PMC article. Review.
Neurofibromatosis type 2 protein (NF2) is an underappreciated tumor suppressor involved in a broad range of nervous system tumors. Inactivation of the NF2 gene leads to neurofibromatosis type-2, which is characterized by mul
Neurofibromatosis type 2 protein (NF2) is an underappreciated tumor suppressor involved in a broad range of nerv
Neurofibromatosis type 2 (NF2): diagnosis and management.
Lloyd SK, Evans DG. Lloyd SK, et al. Handb Clin Neurol. 2013;115:957-67. doi: 10.1016/B978-0-444-52902-2.00054-0. Handb Clin Neurol. 2013. PMID: 23931824 Review.
Neurofibromatosis type 2 (NF2) is an autosomal dominant inherited tumor predisposition syndrome caused by mutations in the NF2 gene on chromosome 22. ...NF2 represents a difficult management problem with most patients facing substantial m
Neurofibromatosis type 2 (NF2) is an autosomal dominant inherited tumor predisposition syndrome caused by mutati
Neurofibromatosis Type 2.
Ardern-Holmes S, Fisher G, North K. Ardern-Holmes S, et al. J Child Neurol. 2017 Jan;32(1):9-22. doi: 10.1177/0883073816666736. Epub 2016 Sep 29. J Child Neurol. 2017. PMID: 27655473 Review.
Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder (incidence 1:33 000-40 000) characterized by formation of central nervous system tumors, due to mutation in the NF2 gene on chromosome 22q12. ...Careful examination of the skin
Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder (incidence 1:33 000-40 000) characterized b
Neurofibromatosis type 2 (NF2): a clinical and molecular review.
Evans DG. Evans DG. Orphanet J Rare Dis. 2009 Jun 19;4:16. doi: 10.1186/1750-1172-4-16. Orphanet J Rare Dis. 2009. PMID: 19545378 Free PMC article. Review.
Neurofibromatosis type 2 (NF2) is a tumour-prone disorder characterised by the development of multiple schwannomas and meningiomas. ...Neurofibromatosis type 2 is a dominantly inherited tumour predisposition syndrome caused by muta
Neurofibromatosis type 2 (NF2) is a tumour-prone disorder characterised by the development of multiple schwannom
Origins of biallelic inactivation of NF2 in neurofibromatosis type 2.
Xue L, He W, Zhang Y, Wang Z, Chen H, Chen Z, Zhu W, Liu D, Jia H, Jiang Y, Wang Z, Wu H. Xue L, et al. Neuro Oncol. 2022 Jun 1;24(6):903-913. doi: 10.1093/neuonc/noab287. Neuro Oncol. 2022. PMID: 34918118 Free PMC article.
METHODS: A cohort of 60 NF2 patients was recruited. Next-generation sequencing of tumor and paired control samples was used to explore how NF2 mutations evolve in determining the clinical phenotypes. ...While a number of NF2 patients were found without germli …
METHODS: A cohort of 60 NF2 patients was recruited. Next-generation sequencing of tumor and paired control samples was used to explor …
1,845 results